Genzyme, FDA Warn Of Foreign Particles Found In Some Lots Of Five Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Although the drugs in question all are manufactured or finished and filled at the Allston Landing, Mass., plant, Genzyme says the current difficulty is not related to prior manufacturing problems associated with that facility.
You may also be interested in...
FDA Inspection Of Genzyme Plant Finds Lack Of Follow-up, Old Equipment, Poor Personnel Qualification
A Form 483 posted online by FDA following a five-week inspection of the Allston Landing manufacturing plant cites 49 separate concerns.
FDA Inspection Of Genzyme Plant Finds Lack Of Follow-up, Old Equipment, Poor Personnel Qualification
A Form 483 posted online by FDA following a five-week inspection of the Allston Landing manufacturing plant cites 49 separate concerns.
Shire Seizes On Gaucher Opening With EMEA Filing For Velaglucerase
Given the shortage of Genzyme's Cerezyme treatment, European regulators decided to grant an accelerated review for Shire's medication.